References
- Driscoll J. S., Hazard G. F., Wood H. B., Goldin A. Structure-antitumour activity relationships among quinone derivatives. Cancer Chem. Rep. 1974; 2: 1–362
- Szmigiero L., Kohn K. W. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (Diaziquone) in isolated nuclei from human cells. Cancer Res. 1984; 44: 4453–4457
- Szmigiero L., Erickson L. C., Ewig R. A., Kohn K. W. DNA strand scission and cross-linking by diaziridinylbenzoquinone (Diaziquone) in human cells and relation to cell killing. Cancer Res. 1984; 44: 4447–4452
- Dzielendziak A., Butler J. 1,4-benzoquinones: New diaziridinyl analogues and improved methods of synthesis. Synthesis 1989; 643–646
- Butler J., Hoey B. M., Ward T. M. The alkylation of DNA in vitro by 2,5-bis(2-hydroxyethylamino)-3,6-diaziridinyl-l,4-benzoquinone (BZQ) - I. Biochem. Pharmcicol. 1989; 38: 923–927
- Chou F., Khan A. H., Driscoll J. S. Potential central nervous system antiturnour agents: aziridinylbenzoquinones 2. J. Med. Cheni. 1976; 19: 1302–1307
- Lea J. S., Garner H. J., Butler J., Hoey B. M., Ward T. H. The lack of correlation between toxicity and free radical formation of two diaziridinyl benzoquinones. Biochem. Pharmacol. 1988; 37: 2023–2025
- Butler J., Hoey B. M., Lea J. S. The reduction of anti-tumour diaziridinyl benzoquinones. Biochim. Biophps. Acta 1987; 925: 144–149
- Bosanquet A. G., McLoughlin S. B. Stability of 2,5-diaziridinyl-3,6-bis(hydroxyethylamino)-1.4-benzoquinone (BZQ; NSC 224070) in aqueous solution by high-performance liquid chromatography. Invest. New Drugs 1985; 3: 43–50
- Gutteriez P. L. Mechanisms of bioreductive activation. The example of Diaziquone (AZQ). Free Rad. Biol. Med. 1989; 6: 405–445
- Ilan Y. A., Meisel D., Czapski G. The redox potential of the O2-O2− system in aqueous media. Istael J. Chem. 1974; 12: 891–895
- Hoey B. M., Butler J., Swallow A. J. Reductive activation of Mitomycin C. Biochem. 1988; 27: 2608–2614
- Wike-Hooky J. L., Haveman J., Reinhold H. S. The relevance of tumour pH to the treatment of malignant disease. Radiother. Oncol. 1984; 2: 343–366
- Butler J., Hoey B. M. The apparent inhibition of superoxide dismutase activity by quinones. J. Free Rad. Biol. Med. 1986; 2: 77–81
- Dzielendziak A., Butler J., Hoey B. M., Lea J. S., Ward T. H. A comparison of the structural and cytotoxic activity of novel AZQ analogues. 1989, submitted